Prospective Evaluation of Spleen Injury Treatments in Languedoc Roussillon

Descriptive, prospective, multicenter evaluation of spleen injury treatment in the Languedoc Roussilon region according to trauma severity, morbi-mortality and length of hospitalization.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Trauma Wounds and Injuries

Age range

16 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Centre Hospitalier d'Alès, Alès, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Hospitalized for abdominal trauma
diagnosis of splenic contusion confirmed by scanner or during surgery for hemodynamically unstable cases
patient has signed a consent form
patient is a beneficiary of or affiliated with a social security program

Exclusion criteria

Refuses to participate
Pregnant or breastfeeding
Patient under guardianship

Treatment and study plan

Primary outcomes

Number of deceased participants

Time frame: 1 year

Mortality

Secondary outcomes

Number of participants with certain morbidities

Time frame: 3 months of follow up

The occurrence of pulmonary, thrombo-embolic, hemorrhagic, pancreatic, splenic and infectious morbidities are recorded.
Days in hospital

Time frame: 1 year of follow up
Direct costs (euros per patient)

Time frame: 1 year of follow up

Costs are calculated as a function of hospitalisation, surgical procedures, interventional radiology.

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Nīmes

Other

Registry information

Official study title

Prospective Evaluation of Spleen Injury Treatments in Languedoc Roussilon, France

Important dates

Study start: 2010
Primary completion: 2013
Study completion: 2013
First posted: Apr 15, 2010
Registry last updated: Nov 17, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed